Ergonomic Recommendations in Ultrasound-Guided Botulinum Neurotoxin Chemodenervation for Spasticity: An International Expert Group Opinion

• Published in: Toxins 2021-03, Vol.13 (4), p.249
• Main Authors: Lagnau, Philippe, Lo, Alto, Sandarage, Ryan, Alter, Katharine, Picelli, Alessandro, Wissel, Jorg, Verduzco-Gutierrez, Monica, Suputtitada, Areerat, Munin, Michael C, Carda, Stefano, Khan, Omar, Koçer, Serdar, Reebye, Rajiv
• Format: Article
• Language: English
• Subjects: Accuracy; Acetylcholine Release Inhibitors - administration & dosage; Acetylcholine Release Inhibitors - adverse effects; botulinum neurotoxin; Botulinum toxin; Botulinum Toxins - administration & dosage; Botulinum Toxins - adverse effects; chemodenervation; Clinical outcomes; Consensus; Ergonomics; Health Care Surveys; Humans; Injection; Injections, Intramuscular; Injuries; Injury prevention; Medical personnel; muscle spasticity; Muscle Spasticity - diagnosis; Muscle Spasticity - drug therapy; Muscle Spasticity - physiopathology; Muscle, Skeletal - diagnostic imaging; Muscle, Skeletal - innervation; Muscles; Nerve Block; Neurotoxins; Occupational Health; Occupational Injuries - etiology; Occupational Injuries - prevention & control; Opinion; Optimization; Pain; Patient Positioning; Patients; Physicians; Positioning devices (machinery); Posture; Spasticity; Toxins; Treatment Outcome; Ultrasonic imaging; Ultrasonography, Interventional; Ultrasound; ultrasound-guided; Work environment; Workstations
• ISSN: 2072-6651; 2072-6651
• DOI: 10.3390/toxins13040249

Ultrasound (US)-guided botulinum neurotoxin (BoNT) injections are becoming a mainstay in the treatment of muscle spasticity in upper motor neuron syndromes. As a result, there has been a commensurate increase in US-guided BoNT injection for spasticity training courses. However, many of these courses do not emphasize the importance of ergonomics. This paper aims to highlight the importance of ultrasound ergonomics and presents ergonomic recommendations to optimize US-guided BoNT injection techniques in spasticity management. Expert consensus opinion of 11 physicians (4 different continents; representing 8 countries, with an average of 12.6 years of practice using US guidance for BoNT chemodenervation (range 3 to 22 years)). A search using PubMed, College of Physicians and Surgeons of British Columbia database, EMbase was conducted and found no publications relating the importance of ergonomics in US-guided chemodenervation. Therefore, recommendations and consensus discussions were generated from the distribution of a 20-question survey to a panel of 11 ultrasound experts. All 11 surveyed physicians considered ergonomics to be important in reducing physician injury. There was complete agreement that physician positioning was important; 91% agreement that patient positioning was important; and 82% that ultrasound machine positioning was important. Factors that did not reach our 80% threshold for consensus were further discussed. Four categories were identified as being important when implementing ultrasound ergonomics for BoNT chemodenervation for spasticity; workstation, physician, patient and visual ergonomics. Optimizing ergonomics is paramount when performing US-guided BoNT chemodenervation for spasticity management. This includes proper preparation of the workspace and allowing for sufficient pre-injection time to optimally position both the patient and the physician. Lack of awareness of ergonomics for US-guided BoNT chemodenervation for spasticity may lead to suboptimal patient outcomes, increase work-related injuries, and patient discomfort. We propose key elements for optimal positioning of physicians and patients, as well as the optimal setup of the workspace and provide clinical pearls in visual identification of spastic muscles for chemodenervation.